Literature DB >> 30529837

Clinicopathological study of role of CD34 expressions in the stroma of premalignant and malignant lesions of uterine cervix.

Mohsin Aijaz1, Kiran Alam2, Veena Maheshwari2, Seema Hakim3, Maria Kamal2.   

Abstract

CD34 is a transmembrane glycoprotein that is thought to be involved in the modulation of cell adhesion and signal transduction. The connective tissue stroma of virtually all human organs contain large amounts of resident CD34+ fibrocytes, which are involved in multiple functions such as wound healing, secretion of cytokines and also participate in stromal remodeling. It has been seen in various studies that absence of CD34+ fibrocytes within the stroma is associated with invasive carcinomas. In our study, we also investigated the presence and distribution of CD34+ fibrocytes in cervical intraepithelial neoplasia, invasive cervical carcinoma and adjacent normal cervical stroma. It was seen that normal cervical stroma and the stroma adjacent to cervical intra epithelial lesions harbours a dense meshwork of CD34+ fibrocytes, whereas the stroma of invasive carcinoma was nearly devoid of this cell population. Early stromal invasion by squamous carcinoma was characterized by a focal loss of CD34+ fibrocytes. This can be used as a sensitive tool in detecting tiny foci of stromal invasion in early cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD34 fibrocyte; Transduction; Transmembrane; stromal remodeling

Mesh:

Substances:

Year:  2018        PMID: 30529837     DOI: 10.1016/j.anndiagpath.2018.11.007

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  3 in total

1.  Clinical Features, Management, and Prognostic Factors of Intracranial Solitary Fibrous Tumor.

Authors:  Jingdian Liu; Sisi Wu; Kai Zhao; Junwen Wang; Kai Shu; Ting Lei
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

2.  Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.

Authors:  Arik Bernard Schulze; Lars Henning Schmidt; Birthe Heitkötter; Sebastian Huss; Michael Mohr; Alessandro Marra; Ludger Hillejan; Dennis Görlich; Peter J Barth; Jan Rehkämper; Georg Evers
Journal:  Thorac Cancer       Date:  2019-11-24       Impact factor: 3.500

3.  CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer.

Authors:  Yun Lin; Zhi Li; Mubiao Liu; Haiyan Ye; Jianhui He; Jianguo Chen
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.